Efficacy of Tricyclic Antidepressant Therapy in Adults With Cyclic Vomiting Syndrome: A Two-year Follow-up Study
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
AIM: To investigate the effects of prolonged tricyclic antidepressants (TCAs) therapy on the frequency and duration of episodes of cyclic vomiting syndrome (CVS) in adults, and the global assessment of clinical improvement and the number of emergency department (ED) visits and/or hospitalizations. METHOD: An open labeled study was conducted in adult CVS patients treated with a TCA and followed for up to 2 years. Demographic data, TCA dosage, duration and frequency of CVS episodes, ED visits, and hospitalizations at baseline and during TCA therapy were recorded, and patients were monitored for any adverse events. RESULTS: Forty-six patients initially met the inclusion criteria and 41 patients (22 male) with mean age of 35 years (range: 18 to 63 y) on TCA were able to be followed for 1 year and 23 were evaluated for 2 years. Mean age of onset of CVS symptoms was 26 years (range: 10 to 52 y) and mean age for making the diagnosis of CVS was 32 years (range: 15 to 63 y). The frequency and duration of an episode and ED visits related to CVS were all significantly reduced after both the first and second year of TCA therapy (P<0.05). Eighty-eight percent reported an improved clinical status by subjective global assessment. Mild side effects were reported in 34% not necessitating stoppage of the TCA. CONCLUSIONS: Long-term TCA therapy significantly reduces the frequency and duration of CVS episodes, ED visits, and hospitalizations (P<0.05), and improves overall clinical well-being providing evidence that they are effective therapy for adult CVS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The evidence on the use of TCAs in adults with CVS is based on open‐label and retrospective studies and two randomized controlled trials (RCTs) in children.”
In the citing paper
“Across these studies, 413/600 (70%) of patients reported complete or partial improvement with a decrease in frequency, duration, or severity of CVS symptoms when treated with a TCA, most commonly amitriptyline.”
In the citing paper
“There were fourteen studies that included 600 adult and pediatric patients.”
In the citing paper
“The mean effective dose in adults is 75‐100 mg daily or 1‐1.5 mg/kg body weight.”
In the citing paper
“The prevalence of migraine headaches in adults with CVS varies between 13% and 70%.15 75”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“The usual dose that was effective in these conditions, especially in FGID, is lower than the traditional antidepressant doses.(13,16) This finding is echoed in our study, as the median dose of 100mg/d is much lower than the doses used in the past for psychiatric indications.”
ResultOnghena, P., & Van Houdenhove, B. (1992) · Pain · doi:10.1016/0304-3959(92)90144-z · Cited by 563
Central neurocircuitry associated with emesis
Hornby, P. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00849-x · Cited by 432 · cited 1×
“This area of the brain receives input from the area postrema and abdominal vagus through the nucleus tractus solitarius.(20,21) Although the exact etiology of CVS is unknown, it could be possible that this area of the brain is activated by the various factors or ‘‘triggers’’ of CVS leading to manifestation of the vomi…”
BackgroundTrindade, E. M., Menon, D., Topfer, L.-A., & Coloma, C. (1998) · Europe PMC (PubMed Central) · Cited by 317
The Use of Antidepressants in the Treatment of Chronic Pain: A Review of the Current Evidence
Magni, G. (1991) · Drugs · doi:10.2165/00003495-199142050-00002 · Cited by 244
Cyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management
Fleisher, D. R., Gornowicz, B., Adams, K., Burch, R., & Feldman, E. J. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-20 · Cited by 215 · cited 9×
“There are little data on preventive treatment in adult CVS.4,7 Our recent report on the overall treatment experience in 24 patients who received amitriptyline for at least 3 months indicated that 93% had a favorable response with decreased frequency and severity of their symptoms and 26% achieved full remission.4 Prak…”
InfluentialCyclic vomiting syndrome in adults
Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01113.x · Cited by 194 · cited 1×
“The patient population demographics are similar to the other published adult CVS cohorts in terms of male predominance (54%), personal or family history of migraine diathesis (36%), and marijuana use (53%).(4,5,7,18) Although 1 study had a female/male ratio of 1.”
MethodSelf-citationIs cyclic vomiting syndrome related to migraine?
Li, B. U. K., Murray, R. D., Heitlinger, L. A., Robbins, J. L., & Hayes, J. R. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70242-8 · Cited by 185 · cited 1×
“CVS was first described in the late 19th century and was essentially thought to be a disorder of childhood, but it is increasingly being recognized in adults over the last 20 years.(2) The diagnostic criteria for adult CVS according to the Rome III criteria are stereotypic episodes of vomiting with the following chara…”
BackgroundCyclic Vomiting Syndrome: Evolution in Our Understanding of a Brain-Gut Disorder
Li, B. U. K., & Balint, J. P. (2000) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00096-8 · Cited by 184 · cited 2×
“Cyclic vomiting syndrome (CVS) is a disease characterized by recurrent and stereotypic episodes of incapacitating nausea and vomiting interspersed with relatively symptom-free intervals that might last anywhere from a few weeks to months.(1) CVS was first described in the late 19th century and was essentially thought…”
BackgroundNamin, F., Patel, J., Lin, Z., Sarosiek, I., Foran, P., Esmaeili, P., & Mccallum, R. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00867.x · Cited by 129 · cited 5×
“There are little data on preventive treatment in adult CVS.(4,7) Our recent report on the overall treatment experience in 24 patients who received amitriptyline for at least 3 months indicated that 93% had a favorable response with decreased frequency and severity of their symptoms and 26% achieved full remission.”
BackgroundMethodInfluentialSelf-citation
Cited by
Cannabinoid Hyperemesis Syndrome
A. Galli, J., Andari Sawaya, R., & K. Friedenberg, F. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104040241 · Cited by 303
“For example, in two recently published series of adult patients with CVS, approximately one third of patients reported daily marijuana use [65,66].”
BackgroundVenkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome
Venkatesan, T., Levinthal, D. J., Li, B. U. K., Tarbell, S. E., Adams, K. A., Issenman, R. M., Sarosiek, I., Jaradeh, S. S., Sharaf, R., Sultan, S., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13606 · Cited by 173
“Conversely, another case series of patients with CVS with high proportions of cannabis users reported >80% response rates to tricyclic medications.(185) Moreover, Venkatesan et al.”
BackgroundLevetiracetam Mechanisms of Action: From Molecules to Systems
Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131
“Clinical studies have shown in adult patients and elderly patients that LEV (initial dose was 500 mg/day and increased in 500 mg increments, n a twice daily dosing regimen, to a median dose of 1000 mg per day) is effective for prophylaxis against cyclic vomiting syndrome episodes [86,87].”
BackgroundPharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review
Richards, J. R., Gordon, B. K., Danielson, A. R., & Moulin, A. K. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1931 · Cited by 126
Metadata
- Authors
- Hejazi, R. A., Reddymasu, S. C., Namin, F., Lavenbarg, T., Foran, P., & McCallum, R. W.
- Affiliations
- University of Kansas Medical Center (US)
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-01
- Volume
- 44
- Issue
- 1
- Pages
- 18-21
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2015299208
- Cited by
- 84
- References
- 24
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 2 · 2020: 5 · 2019: 9 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- cyclic vomiting syndrome, tricyclic antidepressants, adult patients, emergency department visits, hospitalization, adverse drug reactions, Subjective Global Assessment
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Tricyclic, Dose-Response Relationship, Drug, Emergency Service, Hospital, Female, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Periodicity, Severity of Illness Index, Syndrome, Time Factors, Vomiting, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Tricyclic Antidepressant Therapy in Adults With Cyclic Vomiting Syndrome: A Two-year Follow-up Study. https://app.cochat.ai/papers/10.1097/mcg.0b013e3181ac6489
- The paper
- Hejazi, R. A., Reddymasu, S. C., Namin, F., Lavenbarg, T., Foran, P., & McCallum, R. W. (2010). Efficacy of Tricyclic Antidepressant Therapy in Adults With Cyclic Vomiting Syndrome: A Two-year Follow-up Study. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0b013e3181ac6489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.